HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin Camphausen Selected Research

Radiation-Sensitizing Agents

1/2021The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
1/2018LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation.
2/2012Radiosensitization by the novel DNA intercalating agent vosaroxin.
8/2009CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
2/2008In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin Camphausen Research Topics

Disease

127Neoplasms (Cancer)
01/2022 - 06/2002
31Glioma (Gliomas)
01/2022 - 09/2003
30Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2009
17Brain Neoplasms (Brain Tumor)
01/2019 - 04/2005
17Prostatic Neoplasms (Prostate Cancer)
02/2012 - 12/2003
13Breast Neoplasms (Breast Cancer)
02/2021 - 02/2006
12Neoplasm Metastasis (Metastasis)
01/2020 - 05/2006
8Carcinoma (Carcinomatosis)
06/2022 - 01/2004
5Disease Progression
02/2021 - 07/2009
4Triple Negative Breast Neoplasms
10/2015 - 10/2009
3Radiation Injuries (Radiation Sickness)
01/2022 - 12/2003
3Stomach Neoplasms (Stomach Cancer)
09/2020 - 01/2012
3Urinary Bladder Neoplasms (Bladder Cancer)
09/2020 - 08/2006
3Hypoxia (Hypoxemia)
10/2017 - 04/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
12/2016 - 05/2006
3Vaccinia
08/2008 - 06/2004
2Melanoma (Melanoma, Malignant)
09/2020 - 07/2011
2Neoplasm Micrometastasis
10/2015 - 10/2009
2Hypertension (High Blood Pressure)
10/2014 - 02/2009
2Paraganglioma (Paragangliomas)
01/2014 - 04/2013
2Pheochromocytoma
01/2014 - 04/2013
2Diffuse Intrinsic Pontine Glioma
07/2012 - 07/2012
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2011 - 01/2010
2Fowlpox
08/2008 - 05/2005
2Proctitis
01/2008 - 07/2006

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2003
13DNA (Deoxyribonucleic Acid)IBA
09/2020 - 05/2004
11Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2006
11Biological ProductsIBA
12/2021 - 06/2003
11Pharmaceutical PreparationsIBA
01/2021 - 04/2005
11Histone Deacetylase InhibitorsIBA
01/2020 - 01/2004
8Temozolomide (Temodar)FDA LinkGeneric
06/2020 - 02/2008
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2020 - 02/2004
7VaccinesIBA
11/2011 - 06/2004
6Phosphotransferases (Kinase)IBA
10/2021 - 05/2009
6CytokinesIBA
01/2021 - 12/2005
6Histones (Histone)IBA
01/2020 - 09/2004
5Radiation-Sensitizing AgentsIBA
01/2021 - 02/2008
5Valproic Acid (Depakote)FDA LinkGeneric
03/2020 - 04/2005
5Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 01/2004
5VorinostatFDA Link
01/2020 - 06/2009
5Carcinoembryonic AntigenIBA
11/2011 - 06/2004
5AntigensIBA
08/2008 - 06/2004
4Small Interfering RNA (siRNA)IBA
01/2022 - 01/2018
4RNA (Ribonucleic Acid)IBA
09/2020 - 05/2004
4ChromatinIBA
01/2018 - 01/2004
4trans-sodium crocetinate (crocetin)IBA
02/2012 - 04/2009
4Angiogenesis InhibitorsIBA
11/2009 - 05/2003
4Amifostine (Ethyol)FDA LinkGeneric
01/2008 - 12/2003
3MicroRNAs (MicroRNA)IBA
02/2021 - 09/2014
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
3Anticonvulsants (Antiepileptic Drugs)IBA
11/2018 - 02/2009
3Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2018 - 07/2015
3LB100IBA
01/2018 - 07/2015
3Oxygen (Dioxygen)IBA
10/2017 - 04/2009
3Coloring Agents (Dyes)IBA
09/2014 - 02/2004
3Fluorouracil (Carac)FDA LinkGeneric
02/2013 - 08/2011
3SuspensionsIBA
03/2012 - 07/2006
3Monoclonal AntibodiesIBA
09/2011 - 06/2005
3Docetaxel (Taxotere)FDA Link
02/2010 - 02/2006
3Capecitabine (Xeloda)FDA Link
02/2010 - 06/2007
3EndostatinsIBA
04/2004 - 01/2004
2Peptide Initiation Factors (Initiation Factor)IBA
01/2022 - 05/2012
2Eukaryotic Initiation Factor-4F (EIF4F)IBA
10/2021 - 01/2014
2Eukaryotic Initiation Factor-4EIBA
10/2021 - 05/2012
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 12/2005
2A-Form DNA (A-DNA)IBA
10/2019 - 02/2008
2Adenosine Triphosphate (ATP)IBA
01/2019 - 01/2014
2Messenger RNA (mRNA)IBA
01/2018 - 12/2011
2Transcription Factors (Transcription Factor)IBA
01/2017 - 12/2005
2salicylhydroxamic acid (SHAM)IBA
10/2015 - 04/2003
2Sunitinib (Sutent)FDA Link
10/2014 - 03/2013
2Polo-Like Kinase 1IBA
09/2013 - 12/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2013 - 01/2012
2ChemokinesIBA
01/2013 - 07/2011
2dipinacoline glutamateIBA
07/2012 - 07/2012
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2012 - 12/2005
2DepsipeptidesIBA
12/2011 - 01/2010
2Radioisotopes (Radionuclides)IBA
03/2011 - 07/2008
2Indicators and Reagents (Reagents)IBA
02/2010 - 09/2004
2Bevacizumab (Avastin)FDA Link
02/2009 - 02/2006
2Prostate-Specific Antigen (Semenogelase)IBA
08/2008 - 05/2005
2Fas Ligand Protein (Fas Ligand)IBA
08/2008 - 06/2004
2Neoplasm Antigens (Tumor Antigens)IBA
07/2008 - 09/2007
2Cancer VaccinesIBA
09/2007 - 05/2005
217- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
09/2006 - 12/2004
2entinostat (MS 275)IBA
09/2004 - 01/2004
2alvocidib (flavopiridol)IBA
07/2004 - 04/2004

Therapy/Procedure

70Radiotherapy
06/2022 - 04/2003
49Therapeutics
01/2022 - 06/2002
10Drug Therapy (Chemotherapy)
01/2020 - 01/2004
9Immunotherapy
09/2020 - 06/2003
5Re-Irradiation
12/2021 - 12/2005
5Aftercare (After-Treatment)
01/2019 - 12/2003
4Brachytherapy
08/2006 - 08/2004
3Chemoradiotherapy
06/2022 - 01/2010
2Craniospinal Irradiation
12/2021 - 09/2011
2Diet Therapy (Therapy, Diet)
01/2020 - 06/2013
2Caloric Restriction
07/2014 - 06/2013
2Injections
01/2010 - 09/2004